Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Research and development | 118M | 119M |
| Selling, general and administrative | 61M | 59M |
| Operating expenses | 179M | 178M |
| Operating income | −179M | −178M |
| Pre-tax income | −290M | −154M |
| Income tax | −2M | 2M |
| Net income | −288M | −155M |
| Earnings per share | −3.08 | −2.30 |
| Earnings per share, diluted | −3.08 | −2.30 |
| Weighted average shares | 94M | 67M |
| Weighted average shares, diluted | 94M | 67M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 466M | 150M | 186M | 222M | 260M | 165M | 207M | 229M |
| Current assets | 511M | 191M | 242M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −157M | −119M |
| Depreciation and amortisation | 216,000 | 233,000 |
| Share-based compensation | 14M | 20M |
| Capital expenditure | — | 0 |
| Investing cash flow | — | 0 |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 276M |
| 305M |
| 201M |
| 234M |
| 265M |
| Total assets | 532M | 210M | 256M | 294M | 319M | 214M | 247M | 279M |
| Current liabilities | 154M | 248M | 197M | 31M | 30M | 34M | 26M | 22M |
| Short-term debt | 0 | 18M | 13M | 8M | 9M | 6M | 2M | — |
| Long-term debt | 50M | 14M | 19M | 23M | 22M | 25M | 28M | 29M |
| Total liabilities | 205M | 263M | 218M | 131M | 124M | 59M | 54M | 52M |
| Equity | 327M | −53M | 38M | 163M | 195M | 155M | 193M | 226M |
| Shares outstanding | 135M | 96M | 96M | 94M | 93M | 69M | 68M | 68M |
| Shares issued | 135M | 96M | 96M | 94M | 93M | 69M | 68M | 68M |
| 141M |
| 64M |